OR51M1
gene geneOn this page
Summary
OR51M1 (olfactory receptor family 51 subfamily M member 1, HGNC:14847) is a protein-coding gene on chromosome 11p15.4, encoding Olfactory receptor 51M1 (Q9H341). Odorant receptor.
Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome.
Source: NCBI Gene 390059 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- MANE Select transcript:
NM_001004756
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:14847 |
| Approved symbol | OR51M1 |
| Name | olfactory receptor family 51 subfamily M member 1 |
| Location | 11p15.4 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000184698 |
| Ensembl biotype | protein_coding |
| Entrez | 390059 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 2 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000328611, ENST00000641529, ENST00000642046
RefSeq mRNA: 1 — MANE Select: NM_001004756
NM_001004756
CCDS: CCDS53596
Canonical transcript exons
ENST00000642046 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003812431 | 5385353 | 5385458 |
| ENSE00003813779 | 5389384 | 5393263 |
| ENSE00003814218 | 5383812 | 5383917 |
Expression profiles
Bgee: expression breadth tissue_specific, 2 present calls, max score 76.03.
Top tissues by expression
102 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 76.03 | silver quality |
| bone marrow cell | CL:0002092 | 50.91 | silver quality |
| colonic epithelium | UBERON:0000397 | 46.10 | gold quality |
| bone marrow | UBERON:0002371 | 41.68 | silver quality |
| tonsil | UBERON:0002372 | 40.40 | gold quality |
| stromal cell of endometrium | CL:0002255 | 39.99 | gold quality |
| granulocyte | CL:0000094 | 39.21 | gold quality |
| apex of heart | UBERON:0002098 | 38.61 | silver quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| corpus callosum | UBERON:0002336 | 35.63 | gold quality |
| adrenal tissue | UBERON:0018303 | 35.52 | gold quality |
| monocyte | CL:0000576 | 35.26 | gold quality |
| leukocyte | CL:0000738 | 35.22 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 35.00 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 34.81 | gold quality |
| liver | UBERON:0002107 | 34.58 | gold quality |
| uterine cervix | UBERON:0000002 | 34.49 | gold quality |
| muscle tissue | UBERON:0002385 | 33.35 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 32.32 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| left uterine tube | UBERON:0001303 | 32.07 | gold quality |
| cerebellum | UBERON:0002037 | 32.04 | gold quality |
| cerebellar cortex | UBERON:0002129 | 31.95 | gold quality |
| myometrium | UBERON:0001296 | 31.94 | gold quality |
| ovary | UBERON:0000992 | 31.74 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 31.73 | gold quality |
| cortex of kidney | UBERON:0001225 | 31.62 | gold quality |
| left ovary | UBERON:0002119 | 31.41 | gold quality |
| lymph node | UBERON:0000029 | 31.25 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 5.10 |
Regulation
Is transcription factor: no
Cross-species orthologs
1 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Or51m1 | ENSMUSG00000042219 |
Paralogs (51): OR51E2 (ENSG00000167332), OR51B5 (ENSG00000167355), OR51I1 (ENSG00000167359), OR51Q1 (ENSG00000167360), OR52A5 (ENSG00000171944), OR52W1 (ENSG00000175485), OR51B6 (ENSG00000176239), OR51V1 (ENSG00000176742), OR52E2 (ENSG00000176787), OR51L1 (ENSG00000176798), OR51G2 (ENSG00000176893), OR51A7 (ENSG00000176895), OR51T1 (ENSG00000176900), OR51S1 (ENSG00000176922), OR51F2 (ENSG00000176925), OR51E1 (ENSG00000180785), OR56B4 (ENSG00000180919), OR52E4 (ENSG00000180974), OR52N2 (ENSG00000180988), OR52N1 (ENSG00000181001), OR52N5 (ENSG00000181009), OR56B2 (ENSG00000181017), OR56B1 (ENSG00000181023), OR52N4 (ENSG00000181074), OR52P1 (ENSG00000181109), OR52D1 (ENSG00000181609), OR52H1 (ENSG00000181616), OR52K2 (ENSG00000181963), OR52A1 (ENSG00000182070), OR51B4 (ENSG00000183251), OR52E8 (ENSG00000183269), OR52L1 (ENSG00000183313), OR52B6 (ENSG00000187747), OR51I2 (ENSG00000187918), OR52K1 (ENSG00000196778), OR51D1 (ENSG00000197428), OR51C1 (ENSG00000197674), OR52M1 (ENSG00000197790), OR52E6 (ENSG00000205409), OR52J3 (ENSG00000205495)
Protein
Protein identifiers
Olfactory receptor 51M1 — Q9H341 (reviewed: Q9H341)
Alternative names: Odorant receptor HOR5’beta7, Olfactory receptor OR11-40
All UniProt accessions (1): Q9H341
UniProt curated annotations — full annotation on UniProt →
Function. Odorant receptor.
Subcellular location. Cell membrane.
Similarity. Belongs to the G-protein coupled receptor 1 family.
RefSeq proteins (1): NP_001004756* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000276 | GPCR_Rhodpsn | Family |
| IPR000725 | Olfact_rcpt | Family |
| IPR017452 | GPCR_Rhodpsn_7TM | Domain |
| IPR050402 | OR51/52/56-like | Family |
Pfam: PF13853
UniProt features (24 total): topological domain 8, transmembrane region 7, sequence variant 6, chain 1, glycosylation site 1, disulfide bond 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9H341-F1 | 86.41 | 0.58 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (1): 109–201
Glycosylation sites (1): 16
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-9752946 | Expression and translocation of olfactory receptors |
MSigDB gene sets: 24 (showing top):
GOBP_CELLULAR_RESPONSE_TO_LIPID, GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS, GOBP_RESPONSE_TO_LIPID, KEGG_OLFACTORY_TRANSDUCTION, GOBP_DETECTION_OF_STIMULUS, GOBP_SENSORY_PERCEPTION, GOMF_OLFACTORY_RECEPTOR_ACTIVITY, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, CHEN_METABOLIC_SYNDROM_NETWORK, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY, GOBP_SENSORY_PERCEPTION_OF_SMELL, GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, GOBP_DETECTION_OF_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION, HBZ_TARGET_GENES, REACTOME_OLFACTORY_SIGNALING_PATHWAY
GO Biological Process (6): sensory perception of smell (GO:0007608), cellular response to lipid (GO:0071396), system process (GO:0003008), signal transduction (GO:0007165), G protein-coupled receptor signaling pathway (GO:0007186), detection of chemical stimulus involved in sensory perception of smell (GO:0050911)
GO Molecular Function (3): G protein-coupled receptor activity (GO:0004930), olfactory receptor activity (GO:0004984), signaling receptor activity (GO:0038023)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Olfactory Signaling Pathway | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transmembrane signaling receptor activity | 2 |
| sensory perception of chemical stimulus | 1 |
| response to lipid | 1 |
| cellular response to chemical stimulus | 1 |
| multicellular organismal process | 1 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| sensory perception of smell | 1 |
| detection of chemical stimulus involved in sensory perception | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| detection of chemical stimulus involved in sensory perception of smell | 1 |
| molecular transducer activity | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
196 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| OR51M1 | FAM221A | A4D161 | 571 |
| OR51M1 | ZNF417 | Q8TAU3 | 447 |
| OR51M1 | UNC93A | Q86WB7 | 435 |
| OR51M1 | HBE1 | P02100 | 379 |
| OR51M1 | NPBWR2 | P48146 | 371 |
| OR51M1 | ADGRG7 | Q96K78 | 354 |
| OR51M1 | GRIP2 | Q9C0E4 | 329 |
| OR51M1 | GLRA2 | P23416 | 324 |
| OR51M1 | A0A0J9YYA3 | A0A0J9YYA3 | 298 |
| OR51M1 | SLC5A11 | Q8WWX8 | 290 |
| OR51M1 | FOLR2 | P14207 | 289 |
| OR51M1 | FOLR1 | P15328 | 269 |
| OR51M1 | HBD | P02042 | 249 |
| OR51M1 | HRNR | Q86YZ3 | 238 |
| OR51M1 | RPS13 | P19116 | 227 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| OR51M1 | HDLBP | psi-mi:“MI:0915”(physical association) | 0.400 |
BioGRID (2): OR51M1 (Proximity Label-MS), OR51M1 (Negative Genetic)
ESM2 similar proteins: A0A3B3IT45, A6NGY5, O88628, P0C646, Q6IFG1, Q8NGF0, Q8NGF1, Q8NGF3, Q8NGH6, Q8NGH7, Q8NGH9, Q8NGI0, Q8NGI2, Q8NGJ2, Q8NGJ3, Q8NGJ4, Q8NGJ5, Q8NGJ6, Q8NGJ7, Q8NGJ9, Q8NGK1, Q8NGK2, Q8NGK3, Q8NGK4, Q8NGK5, Q8NGK6, Q8NH53, Q8NH55, Q8NH56, Q8NH57, Q8NH59, Q8NH60, Q8NH61, Q8NH63, Q8NH64, Q8TCB6, Q8VBV9, Q96RD2, Q96RD3, Q9H255
Diamond homologs: A0A3B3IT45, A4D2G3, A6NF89, A6NGY5, A6NL08, A6NL26, A6NMU1, A6NND4, O88628, P0C629, P0C646, P0C7N1, P0C7T3, P23266, P23273, P23274, P30954, Q13606, Q60888, Q62007, Q6IF63, Q6IFG1, Q6W049, Q8NGA6, Q8NGF0, Q8NGF1, Q8NGF3, Q8NGG8, Q8NGH5, Q8NGH6, Q8NGH7, Q8NGH8, Q8NGH9, Q8NGI0, Q8NGI1, Q8NGI2, Q8NGI3, Q8NGI7, Q8NGJ2, Q8NGJ3
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
0 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
367 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:5389868:GCC:G | donor_gain | 0.7100 |
| 11:5390042:T:TG | donor_gain | 0.6300 |
| 11:5389976:ACCAG:A | acceptor_gain | 0.6200 |
| 11:5389977:C:G | acceptor_gain | 0.6200 |
| 11:5389980:GGAA:G | acceptor_gain | 0.6100 |
| 11:5389965:ATTTT:A | acceptor_gain | 0.6000 |
| 11:5390006:A:G | donor_gain | 0.6000 |
| 11:5390043:A:AA | donor_gain | 0.5900 |
| 11:5390182:G:GG | donor_gain | 0.5900 |
| 11:5389496:A:T | donor_gain | 0.5800 |
| 11:5390178:GCTA:G | donor_gain | 0.5800 |
| 11:5387467:CCCT:C | donor_gain | 0.5700 |
| 11:5389941:T:TA | acceptor_gain | 0.5700 |
| 11:5390045:T:G | donor_gain | 0.5700 |
| 11:5389965:A:AG | acceptor_gain | 0.5500 |
| 11:5389981:G:GT | donor_gain | 0.5500 |
| 11:5389969:T:TA | acceptor_gain | 0.5400 |
| 11:5390039:T:TA | donor_gain | 0.5400 |
| 11:5387465:ACC:A | donor_gain | 0.5300 |
| 11:5387466:CCC:C | donor_gain | 0.5300 |
| 11:5389456:T:G | donor_gain | 0.5300 |
| 11:5390027:AT:A | acceptor_gain | 0.5300 |
| 11:5390179:C:G | donor_gain | 0.5300 |
| 11:5390229:G:GT | donor_gain | 0.5300 |
| 11:5389860:C:A | donor_gain | 0.5200 |
| 11:5389979:A:AG | acceptor_gain | 0.5200 |
| 11:5389980:G:GG | acceptor_gain | 0.5200 |
| 11:5390040:GGT:G | donor_gain | 0.5200 |
| 11:5390174:C:CG | donor_gain | 0.5100 |
| 11:5390176:GT:G | donor_gain | 0.5100 |
AlphaMissense
2140 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:5389966:T:C | F190L | 0.901 |
| 11:5389968:T:A | F190L | 0.901 |
| 11:5389968:T:G | F190L | 0.901 |
| 11:5390224:T:C | F276L | 0.844 |
| 11:5390226:T:A | F276L | 0.844 |
| 11:5390226:T:G | F276L | 0.844 |
| 11:5390185:T:C | F263L | 0.817 |
| 11:5390187:C:A | F263L | 0.817 |
| 11:5390187:C:G | F263L | 0.817 |
| 11:5389738:T:C | F114L | 0.802 |
| 11:5389740:C:A | F114L | 0.802 |
| 11:5389740:C:G | F114L | 0.802 |
| 11:5390188:T:C | F264L | 0.754 |
| 11:5390190:T:A | F264L | 0.754 |
| 11:5390190:T:G | F264L | 0.754 |
| 11:5390311:A:C | S305R | 0.700 |
| 11:5390313:C:A | S305R | 0.700 |
| 11:5390313:C:G | S305R | 0.700 |
| 11:5389930:T:C | F178L | 0.698 |
| 11:5389932:T:A | F178L | 0.698 |
| 11:5389932:T:G | F178L | 0.698 |
| 11:5390319:G:C | K307N | 0.698 |
| 11:5390319:G:T | K307N | 0.698 |
| 11:5389753:T:C | F119L | 0.686 |
| 11:5389755:T:A | F119L | 0.686 |
| 11:5389755:T:G | F119L | 0.686 |
| 11:5389741:T:C | C115R | 0.674 |
| 11:5390064:C:A | D222E | 0.673 |
| 11:5390064:C:G | D222E | 0.673 |
| 11:5389792:T:C | F132L | 0.651 |
dbSNP variants (sampled 300 via entrez): RS1000047262 (11:5382549 A>G), RS1000308839 (11:5391390 C>G), RS1000646475 (11:5383612 T>C), RS1000705979 (11:5388110 T>C), RS1000758485 (11:5387794 C>G), RS1001309702 (11:5392629 C>A,G), RS1001516982 (11:5385823 A>C,T), RS1001550860 (11:5383319 G>A,T), RS1001744890 (11:5387727 C>T), RS1002038039 (11:5384183 G>A), RS1002185076 (11:5388621 T>C), RS1002226674 (11:5391444 G>C), RS1002238924 (11:5388481 A>G), RS1002398217 (11:5392798 G>T), RS1002493826 (11:5384018 G>A,C,T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST010725_20 | Malaria | 4.000000e-69 |
| GCST010725_33 | Malaria | 2.000000e-67 |
| GCST010725_51 | Malaria | 1.000000e-55 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
2 total (human), top 2 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | decreases methylation | 1 |
| Asbestos, Crocidolite | affects expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.